The 3rd Annual China Cross-Border Healthcare Investment Summit
Hangzhou, Chengdu & Shenzhen , Sept 17-22, 2019
Featured roadshow sessions to brand companies’ R&D strength and technology innovation in the core areas of China high-tech and biopharma industry
One-on-one meetings opportunities with 800+ top tier Chinese healthcare investors, 1000+ leading biopharma and biotech industry practitioners
20+ panel discussions with local KOLs and government officials to fully raise the perspective for regulatory and market strategies
Local tour of healthcare industrial chain for in-depth understanding of the market landscape in China
See more details about this event, click here.